Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $51.6M

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) General Information

Description

Neoleukin Therapeutics was a biopharmaceutical company that generated immunotherapies using de novo protein design technology. The firm used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Discovery Tools (Healthcare)
Corporate Office
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Aug-2019 $51.6M 00000 0000 Completed Generating Revenue
1. Early Stage VC 08-Feb-2019 00000 00000 Completed Generating Revenue
To view Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s complete valuation and funding history, request access »

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Board Members (3)

Name Representing Role Since
Sarah Noonberg MD Self Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
WRF Capital Venture Capital Minority 000 0000 000000 0
To view Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s complete investors history, request access »

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) FAQs

  • Where is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) headquartered?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is headquartered in Seattle, WA.

  • What industry is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) in?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s primary industry is Drug Discovery.

  • Is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) a private or public company?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is a Private company.

  • What is the current valuation of Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)?

    The current valuation of Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is 0000.

  • What is Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s current revenue?

    The current revenue for Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) is 000000.

  • How much funding has Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) raised over time?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) has raised $800K.

  • Who are Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s investors?

    WRF Capital has invested in Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals).

  • When was Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) acquired?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) was acquired on 08-Aug-2019.

  • Who acquired Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)?

    Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) was acquired by Neoleukin Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »